Advertisement
Singapore markets closed
  • Straits Times Index

    3,410.81
    -29.07 (-0.85%)
     
  • Nikkei

    40,912.37
    -1.28 (-0.00%)
     
  • Hang Seng

    17,799.61
    -228.67 (-1.27%)
     
  • FTSE 100

    8,203.93
    -37.33 (-0.45%)
     
  • Bitcoin USD

    56,462.53
    -2,206.13 (-3.76%)
     
  • CMC Crypto 200

    1,173.44
    -35.25 (-2.92%)
     
  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     
  • Dow

    39,375.87
    +67.87 (+0.17%)
     
  • Nasdaq

    18,352.76
    +164.46 (+0.90%)
     
  • Gold

    2,399.80
    +30.40 (+1.28%)
     
  • Crude Oil

    83.44
    -0.44 (-0.52%)
     
  • 10-Yr Bond

    4.2720
    -0.0830 (-1.91%)
     
  • FTSE Bursa Malaysia

    1,611.02
    -5.73 (-0.35%)
     
  • Jakarta Composite Index

    7,253.37
    +32.48 (+0.45%)
     
  • PSE Index

    6,492.75
    -14.74 (-0.23%)
     

Insiders Buying Genasys Might Wish They Invested More, Stock Gains 30%

Insiders who bought Genasys Inc. (NASDAQ:GNSS) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$26m as a result of the stock's 30% gain over the same period. As a result, their original purchase of US$167.8k worth of stock is now worth US$225.3k.

While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

View our latest analysis for Genasys

The Last 12 Months Of Insider Transactions At Genasys

Over the last year, we can see that the biggest insider purchase was by Independent Chairman of the Board Richard Osgood for US$100k worth of shares, at about US$2.00 per share. Even though the purchase was made at a significantly lower price than the recent price (US$2.56), we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

ADVERTISEMENT

Genasys insiders may have bought shares in the last year, but they didn't sell any. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
insider-trading-volume

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

Insider Ownership Of Genasys

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Based on our data, Genasys insiders have about 2.5% of the stock, worth approximately US$2.6m. We consider this fairly low insider ownership.

What Might The Insider Transactions At Genasys Tell Us?

It doesn't really mean much that no insider has traded Genasys shares in the last quarter. On a brighter note, the transactions over the last year are encouraging. The transactions are fine but it'd be more encouraging if Genasys insiders bought more shares in the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Genasys. To assist with this, we've discovered 2 warning signs that you should run your eye over to get a better picture of Genasys.

But note: Genasys may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com